Bluejay Therapeutics, a clinical-stage biopharmaceutical company dedicated to developing potentially life-changing ...
By promoting awareness, encouraging preventive practices, and ensuring access to essential healthcare services, the DOH aims ...
Here we go again. From the New York Health Department: Anyone Who Ate Food From ilili Restaurant During January 31 – February ...
The government has set aside £11.8bn to compensate victims of the infected blood scandal, after a public inquiry found the ...
Vietnam Investment Review on MSN3d
Lion TCR's Liocyx-M004 Receives FDA Clearance to Launch Global Multicenter Phase 2 Clinical Trial in HBV-Related Hepatocellular CarcinomaLion TCR announced that its mRNA-encoded T-cell receptor (TCR)-T cell therapy product Liocyx-M004 has received clearance from ...
SHELTON, CT / ACCESS Newswire / February 11, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the 'Company') declared today that it is ready to fight the bird f ...
That means treatment may need to be continued ... In animal studies, Dicerna’s drug cleared nearly 100% of circulating hepatitis B surface antigen (HBsAg), a protein that serves as a biomarker ...
Proceeds expected to fund the start of the ALG-000184 Phase 2 clinical studyFunding expected to extend cash runway into the second half of ...
Russian mRNA cancer 'vaccine' shows promise in pre-clinical trials, part of growing immunotherapy trend in cancer treatment.
GSK has revealed updated results from its phase 2b trial of its antisense drug for hepatitis B virus (HBV ... undetectable after stopping all treatment. In B-Clear, patients with low baseline ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback